Analiza czynników ryzyka zespołu metabolicznego u chorych na zwyrodnienie plamki związane z wiekiem zakwalifikowanych do terapii w ramach programu lekowego „Leczenie neowaskularnej (wysiękowej) postaci zwyrodnienia plamki związanego z wiekiem”
Autorzy: Magdalena Pol, Małgorzata Seredyka-Burduk, Grażyna Malukiewicz

Analysis of Metabolic Syndrome Risk Factors in Patients with Age-related Macular Degeneration Qualified to the Therapy in Drug Prescription Program “Treatment of Neovascular (Exudative) Form of Age-related Macular Degeneration”

Wydanie 2/2018
str. 36 – 39

Autorzy: Magdalena Pol 1 , Małgorzata Seredyka-Burduk 1,2 , Grażyna Malukiewicz 1

1 Katedra i Klinika Chorób Oczu Wydziału Lekarskiego Collegium Medicum w Bydgoszczy Uniwersytetu Mikołaja Kopernika w Toruniu
Kierownik: prof. dr hab. n. med. Grażyna Malukiewicz
2 Zakład Optometrii Wydziału Lekarskiego Collegium Medicum w Bydgoszczy Uniwersytetu Mikołaja Kopernika w Toruniu
Kierownik: dr hab. n. med. Bartłomiej Kałużny


Summary: The pathogenesis of age-related macular degeneration is complex, multifactorial and remains controversial. Aging is the main risk factor but some cardiovascular risk factors are associated with its development and progression as well.

Purpose: The aim of study was the retrospective analysis of some epidemiological features of patients with age-related macular degeneration, who were treated in Drug Prescription Program in Ophthalmological Department in Bydgoszcz in years 2016 and 2017.

Material and Methods: We assessed data of 175 patients. All data derived from medical history files. We took into consideration some modified risk factors of age-related macular degeneration: hypertension, diabetes, dyslipidemia and obesity.

Results: We found hypertension in 75.4% of our patients, diabetes in 22.9%, dyslipidemia in 36%, overweight in 42.86%, obesity in 32.57%.

Conclusion: The cardiovascular risk factors were detected in most of our patients. Understanding the relationship between age-related macular degeneration and cardiovascular risk factors will help us to improve the effectiveness of ophthalmological therapy. Healthy lifestyle, patients’ education and cooperation with general physicians should be an essential part of the treatment.